Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") is proud to announce the launch of its highly anticipated Lord Jones® Live Resin Vapes in two different hardware options. Crafted with the discerning cannabis consumer in mind, these products embody a commitment to excellence, offering an unmatched combination of curated strains, pure live resin, and elegant high-quality hardware.

"We're excited to introduce the latest addition to the evolving Lord Jones® lineup with premium live resin vapes. The Lord Jones® brand epitomizes excellence, and we take pride in bringing exceptional products to market that showcase our commitment to craftsmanship and innovation," said Mike Gorenstein, President, Chairman, and Chief Executive Officer, Cronos. "This launch marks a significant step in further establishing the Lord Jones® brand as one that represents quality and artistry, and we look forward to launching more breakthrough products in 2024."

The live resin format offers consumers a multi-dimensional, true-to-plant experience. This format is well suited for discerning consumers looking to level-up their cannabis experience. The Lord Jones® Live Resin Vapes feature carefully curated strains, which capture natural flavors and aromas and 100% pure live resin, free of additives, ensuring an unadulterated cannabis experience. Each strain was handpicked through multiple rounds of sensory testing to bring consumers the most unique and bold flavor profile and experience. These vapes feature consistent high potency, with THC levels exceeding 70%, and advanced hardware designed to optimize live resin consumption, preserving terpenes and preventing clogging. The lineup also features versatile sizing options, including a 0.5g trial size in the convenience of an all-in-one device and a 1g stock-up size as a 510-thread cartridge, catering to both enthusiasts and those new to the category.

Lord Jones® Live Resin Vapes are available in the following formats:

  • Lord Jones   ®   Purple Lemon Haze Live Resin Vapes
    • Designed to deliver a supremely elevated experience, with notes of zesty citrus, pleasant earthiness, and sharp and spicy pepper flavors
    • Sativa | THC: 72-78%​
    • Available in two hardware options that have been optimized for live resin usage:
      • A unique sleek 0.5g all-in-one device
      • A high-quality 1g 510-thread cartridge
  • Lord Jones   ®   Deadhead OG Live Resin Vapes
    • Designed to deliver a truly complex flavor experience with savory, spicy, and woody flavors
    • Indica | THC: 71-77%​
    • Available in two hardware options that have been optimized for live resin usage:
      • A unique sleek 0.5g all-in-one device
      • A high-quality 1g 510-thread cartridge
  • Lord Jones Live Resin 510-thread battery
    • A 510 battery that fits seamlessly with Lord Jones 1g 510-thread
    • Allows consumers to tailor their vaping experience with this unique live resin optimized battery that includes 5 different voltage settings and extended battery life when compared to conventional 280 mAh vape batteries

Lord Jones® Live Resin Vapes will be available now in Alberta, British Columbia, Manitoba, Ontario, Saskatchewan and Yukon by early 2024. Lord Jones® all-in-one devices will be available in Alberta, Manitoba, Ontario, Saskatchewan and Yukon in 2024. Lord Jones® batteries will be available in Manitoba, Ontario, Saskatchewan and Yukon by early 2024.

To learn more and see the latest announcements on future product launches from the Lord Jones® brand, visit us online at https://lordjones.ca/ and on Instagram at https://www.instagram.com/thelordjones/ .

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about the evolution of the Lord Jones® product lineup; the Lord Jones® brand and the consumer perception thereof; anticipated product launches; the consumer experience with respect to the products discussed herein; anticipated product availability; the Cronos brand portfolio; and Cronos's efforts to advance cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, the Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023, which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

For further information, please contact:

Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com

Investor Relations Contact:
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

CRON:CA,CRON
The Conversation (0)

Trulieve to Open Medical Cannabis Dispensary in Columbus, Georgia

New Muscogee County location will host grand opening celebration Friday, December 20 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF )  ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical cannabis dispensary in Columbus, Georgia .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday December 13

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Latest Press Releases

Related News

×